Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Interesting ratio cash/shares..Gduck
7
Aug 11, 2008 03:39AM
1
Aug 11, 2008 04:16AM


It was stated the deal would be closed on Sept 1st.. so the average price the next 10 days will give us the price... then divid by 7.4 million we will now the share they get....

2.1 Merger Consideration; Conversion of Capital Stock. At the Effective Time, by virtue of the Merger and without any action on the part of Patriot, Subcorp, or Crossflo or their respective stockholders, each share of Crossflo Capital Stock issued and outstanding immediately prior to the Effective Time (exclusive of Dissenting Shares) shall be converted into, and shall represent the right to receive, that portion of the Merger Consideration (as that term is defined below) to which such share is entitled. The Merger Consideration shall consist of the sum of the Initial Cash Consideration (as defined below) and the Initial Stock Consideration (as defined below) less (i) payments made by Buyer to holders of Crossflo’s Secured Convertible Debt (including Buyer) at or before Closing, (ii) the amount of any payment made by Crossflo or by Buyer on behalf of Crossflo to any broker, finder, underwriter, or investment banker related to the transaction described in this Agreement, and (iii) the Estimated Transaction Expenses as described in Section 9.10. The Initial Cash Consideration shall consist of $2,600,000. The initial Stock Consideration shall consist of $7,400,000 in Patriot Common Stock, the value of which shall be based on the average closing price of Patriot Common Stock on The Electronic Bulletin Board as reported by NASDAQ over the ten trading days immediately preceding the Closing.


Aug 11, 2008 05:30AM

Aug 11, 2008 05:36AM
Share
New Message
Please login to post a reply